drugset / Trial / NCT07506512
Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss
NaSingle-groupOpen-labelTreatment
Summary
A prospective cohort study to explore the optimal time interval between mifepristone and misoprostol administration for medical management of early pregnancy loss. Participants will be followed to assess treatment success, satisfaction, and side effects.
Timeline
- Start
- 2026-07
- Primary completion
- 2031-07
- Completion
- 2031-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | Oral |
| Subject | Misoprostol | Other / unclassified | 800 mg | Other |